The alchemy of immune privilege explored from a neuroimmunological perspective

Current Opinion in Pharmacology

Volumn 8, Issue 4, 2008, Pages 480-489

  Arck, Petra Clara ^a,b   Gilhar, Amos ^c   Bienenstock, John ^a   Paus, Ralf ^d  

^a MCMASTER UNIVERSITY   (Canada)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GALECTIN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROBIOTIC AGENT;

ALOPECIA AREATA; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ASTHMA; COLITIS; FETUS WASTAGE; HAIR FOLLICLE; HLA TYPING; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; MENTAL STRESS; MICROENVIRONMENT; MOLECULAR MECHANICS; NEUROIMMUNOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STRESS; UPREGULATION;

ANIMALS; HUMANS; IMMUNE SYSTEM; NERVOUS SYSTEM PHYSIOLOGICAL PHENOMENA; STRESS, PSYCHOLOGICAL;

EID: 51649130866     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2008.06.003     Document Type: Review

References (71)

1. Medawar P.B. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29 (1948) 58-69
2. Barker C.F., and Billingham R.E. Immunologically privileged sites. Adv Immunol 25 (1977) 1-54
3. Streilein J.W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 3 (2003) 879-889
4. Niederkorn J.Y. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 7 (2006) 354-459
5. Mellor A.L., and Munn D.H. Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat Rev Immunol 8 (2008) 74-80
6. Trowsdale J., and Betz A.G. Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 7 (2006) 241-246
7. Filippini A., Riccioli A., Padula F., Lauretti P., D'Alessio A., De Cesaris P., Gandini L., Lenzi A., and Ziparo E. Control and impairment of immune privilege in the testis and in semen. Hum Reprod Update 7 (2001) 444-449
8. Sonnenburg J.L., Angenent L.T., and Gordon J.I. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine?. Nat Immunol 5 (2004) 569-573
9. Prioult G., and Nagler-Anderson C. Mucosal immunity and allergic responses: lack of regulation and/or lack of microbial stimulation?. Immunol Rev 206 (2005) 204-218
10. Xerri L., Devilard E., Hassoun J., Mawas C., and Birg F. Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues. Mol Pathol 50 (1997) 87-91
11. Pudney J., Quayle A.J., and Anderson D.J. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 73 (2005) 1253-1263
12. Paus R., Nickoloff B.J., and Ito T. A 'hairy' privilege. Trends Immunol 26 (2005) 32-40
13. Ito T., Ito N., Saathoff M., Stampachiacchiere B., Bettermann A., Bulfone-Paus S., Takigawa M., Nickoloff B.J., and Paus R. Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol 125 (2005) 1139-1148
14. Ito T., Ito N., Bettermann A., Tokura Y., Takigawa M., and Paus R. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 164 (2004) 623-634
15. Ferguson T.A., and Griffith T.S. A vision of cell death: FasL and immune privilege-10 years later. Immunol Rev 213 (2006) 228-238
16. Hiby S.E., Walker J.J., O'shaughnessy K.M., Redman C.W., Carrington M., Trowsdale J., and Moffett A. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200 (2004) 957-965
17. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., and DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248 (1990) 220-223
18. Guidry P.A., and Stroynowski I. The murine family of gut-restricted class Ib MHC includes alternatively spliced isoforms of the proposed HLA-G homolog, 'blastocyst MHC'. J Immunol 175 (2005) 5248-5259
19. Lila N., Carpentier A., Amrein C., Khalil-Daher I., Dausset J., and Carosella E.D. Implication of HLA-G molecule in heart-graft acceptance. Lancet 355 (2000) 2138
20. Paul P., Rouas-Freiss N., Khalil-Daher I., Moreau P., Riteau B., Le Gal F.A., Avril M.F., Dausset J., Guillet J.G., and Carosella E.D. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci U S A 95 (1998) 4510-4515
21. Wiendl H., Feger U., Mittelbronn M., Jack C., Schreiner B., Stadelmann C., Antel J., Brueck W., Meyermann R., Bar-Or A., et al. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain 128 (2005) 2689-2704
22. Aractingi S., Briand N., Le Danff C., Viguier M., Bachelez H., Michel L., Dubertret L., and Carosella E.D. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?. Am J Pathol 159 (2001) 71-77
23. Khosrotehrani K., Le Danff C., Reynaud-Mendel B., Dubertret L., Carosella E.D., and Aractingi S. HLA-G expression in atopic dermatitis. J Invest Dermatol 117 (2001) 750-752
24. Le Discorde M., Moreau P., Sabatier P., Legeais J.M., and Carosella E.D. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 64 (2003) 1039-1044
25. Carosella E.D., Moreau P., Aractingi S., and Rouas-Freiss N. HLA-G: a shield against inflammatory aggression. Trends Immunol 22 (2001) 553-555
26. Gilhar A., Paus R., and Kalish R.S. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 117 (2007) 2019-2027
27. Gilhar A., and Kalish R.S. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 5 (2006) 64-69
28. Ito T., Ito N., Saatoff M., Hashizume H., Fukamizu H., Nickoloff B.J., Takigawa M., and Paus R. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol 128 (2008) 1196-1206
29. Hanna J., Goldman-Wohl D., Hamani Y., Avraham I., Greenfield C., Natanson-Yaron S., Prus D., Cohen-Daniel L., Arnon T.I., Manaster I., et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 12 (2006) 991-992
30. van den Elsen P.J., Holling T.M., Kuipers H.F., and van der Stoep N. Transcriptional regulation of antigen presentation. Curr Opin Immunol 16 (2004) 67-75
31. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 109 (2003) 685-711
32. Blois S.M., Kammerer U., Alba Soto C., Tometten M.C., Shaikly V., Barrientos G., Jurd R., Rukavina D., Thomson A.W., Klapp B.F., et al. Dendritic cells: key to fetal tolerance?. Biol Reprod 77 (2007) 590-598
33. Blois S.M., Ilarregui J.M., Tometten M., Garcia M., Orsal A.S., Cordo-Russo R., Toscano M.A., Bianco G.A., Kobelt P., Handjiski B., et al. A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 13 (2007) 1450-1457
34. Okazaki T., and Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol 27 (2006) 195-201
35. Piccirillo C.A., and Shevach E.M. Naturally occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol 16 (2004) 81-88
36. Piemonti L., Monti P., Sironi M., Fraticelli P., Leone B.E., Dal Cin E., Allvera P., and Di Carlo V. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 164 (2000) 4443-4451
37. Delgado M., Gonzalez-Rey E., and Ganea D. The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells. J Immunol 175 (2005) 7311-7324
38. Ardavin C. Origin, precursors and differentiation of mouse dendritic cells. Nat Rev Immunol 3 (2003) 582-590
39. Chomarat P., Banchereau J., Davoust J., and Palucka A.K. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 1 (2000) 510-514
40. Scholzen T., Armstrong C.A., Bunnett N.W., Luger T.A., Olerud J.E., and Ansel J.C. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 7 (1998) 81-96
41. Fabricius D., O'Dorisio M.S., Blackwell S., and Jahrsdörfer B. Human plasmacytoid dendritic cell function: inhibition of IFN-alpha secretion and modulation of immune phenotype by vasoactive intestinal peptide. J Immunol 177 (2006) 5920-5927
42. Uddman R., Alumets J., Densert O., Hakanson R., and Sundler F. Occurrence and distribution of VIP nerves in the nasal mucosa and tracheobronchial wall. Acta Otolaryngol 86 (1978) 443-448
43. Jovanovic S., Grbovic L., and Jovanovic A. Pregnancy does not alter the response of uterine arteries to vasoactive intestinal polypeptide. Mol Hum Reprod 6 (2000) 361-368
44. Lacombe A., Lelievre V., Roselli C.E., Muller J.M., Waschek J.A., and Vilain E. Lack of vasoactive intestinal peptide reduces testosterone levels and reproductive aging in mouse testis. J Endocrinol 194 (2007) 153-160
45. Streilein J.W., Okamoto S., Sano Y., and Taylor A.W. Neural control of ocular immune privilege. Ann NY Acad Sci 917 (2000) 297-306
46. Delgado M., and Ganea D. Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma. FASEB J 17 (2003) 1922-1924
47. Lu L.F., Lind E.F., Gondek D.C., Bennett K.A., Gleeson M.W., Pino-Lagos K., Scott Z.A., Coyle A.J., Reed J.L., Van Snick J., et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442 (2006) 997-1002
48. Paus R., Theoharides T.C., and Arck P.C. Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol 27 (2006) 32-39
49. McKay D.M., and Bienenstock J. The interaction between mast cells and nerves in the gastrointestinal tract. Immunol Today 15 (1994) 533-538
50. Yu M., Tsai M., Tam S.Y., Jones C., Zehnder J., and Galli S.J. Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 116 (2006) 1633-1641
51. Wedemeyer J., and Galli S.J. Decreased susceptibility of mast cell-deficient Kit(W)/Kit(W-v) mice to the development of 1,2-dimethylhydrazine-induced intestinal tumors. Lab Invest 85 (2005) 388-396
52. Rabinovich G.A., Liu F.T., Hirashima M., and Anderson A. An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand J Immunol 66 (2007) 143-158
53. Toscano M.A., Commodaro A.G., Ilarregui J.M., Bianco G.A., Liberman A., Serra H.M., Hirabayashi J., Rizzo L.V., and Rabinovich G. Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. J Immunol 176 (2006) 6323-6332
54. Ishibashi S., Kuroiwa T., Sakaguchi M., Sun L., Kadoya T., Okano H., and Mizusawa H. Galectin-1 regulates neurogenesis in the subventricular zone and promotes functional recovery after stroke. Exp Neurol 207 (2007) 302-313
55. Dettin L., Rubinstein N., Aoki A., Rabinovich G.A., and Maldonado C.A. Regulated expression and ultrastructural localization of galectin-1, a proapoptotic beta-galactoside-binding lectin, during spermatogenesis in rat testis. Biol Reprod 68 (2003) 51-59
56. Wollina U., Lange D., Paus R., Burchert M., and Gabius H.J. Expression of galectin-1 and -3 and of accessible binding sites during murine hair cycle. Histol Histopathol 15 (2000) 85-94
57. Gaudier E., Forestier L., Gouyer V., Huet G., Julien R., and Hoebler C. Butyrate regulation of glycosylation-related gene expression: evidence for galectin-1 upregulation in human intestinal epithelial goblet cells. Biochem Biophys Res Commun 325 (2004) 1044-1051
58. Glaser R., and Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 5 (2005) 243-251
59. Qiu B.S., Vallance B.A., Blennerhassett P.A., and Collins S.M. The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Nat Med 5 (1999) 1178-1182
60. Akiyama H., Amano H., and Bienenstock J. Rat tracheal epithelial responses to water avoidance stress. J Allergy Clin Immunol 116 (2005) 318-324
61. Nepomnaschy P.A., Sheiner E., Mastorakos G., and Arck P.C. Stress, immune function, and women's reproduction. Ann NY Acad Sci 1113 (2007) 350-364
62. Loser K., Apelt J., Voskort M., Mohaupt M., Balkow S., Schwarz T., Grabbe S., and Beissert S. IL-10 controls ultraviolet-induced carcinogenesis in mice. J Immunol 179 (2007) 365-371
63. Billingham R.E., and Silvers W.K. A biologist's reflections on dermatology. J Invest Dermatol 57 (1971) 227-240
64. Arck P.C., Handjiski B., Peters E.M., Peter A.S., Hagen E., Fischer A., Klapp B.F., and Paus R. Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol 162 (2003) 803-814
65. Peters E.M., Handjiski B., Kuhlmei A., Hagen E., Bielas H., Braun A., Klapp B.F., Paus R., and Arck P.C. Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am J Pathol 165 (2004) 259-271
66. Peters E.M., Liotiri S., Bodó E., Hagen E., Bíró T., Arck P.C., and Paus R. Probing the effects of stress mediators on the human hair follicle: substance P holds central position. Am J Pathol 171 (2007) 1872-1886
67. Hordinsky M.K., Kennedy W., Wendelschafer-Crabb G., and Lewis S. Structure and function of cutaneous nerves in alopecia areata. J Invest Dermatol 104 (1995) 28S-29S
68. Tometten M., Blois S., Kuhlmei A., Stretz A., Klapp B.F., and Arck P.C. Nerve growth factor translates stress response and subsequent murine abortion via adhesion molecule-dependent pathways. Biol Reprod 74 (2006) 674-683
69. Ng T.F., Lavik E., Keino H., Taylor A.W., Langer R.S., and Young M.J. Creating an immune-privileged site using retinal progenitor cells and biodegradable polymers. Stem Cells 25 (2007) 1552-1559
70. Bienenstock J., Wiley R.E., Neigh G.S., Waserman S., and Keith P. Probiotics in the management and prevention of atopy. Clin Rev Allergy Immunol 22 (2002) 275-285
71. Madsen K., Cornish A., Soper P., McKaigney C., Jijon H., Yachimec C., Doyle J., Jewell L., and De Simone C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121 (2001) 580-591